Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats
- PMID: 12195128
- DOI: 10.1097/00004872-200209000-00031
Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats
Abstract
Objectives: The present study analysed, for the first time, the effects of the flavonoid quercetin in rats after chronic inhibition of nitric oxide (NO) synthesis with Nomega-nitro-L-arginine methyl ester (L-NAME).
Design: Rats were divided randomly into five different treatment groups for 6 weeks: (1) vehicle (control, 1 ml of 1% methylcellulose once daily); (2) vehicle plus L-NAME (75 mg/100 ml in drinking water); (3) quercetin (10 mg/kg p.o. once daily); (4) quercetin (5 mg/kg p.o.) plus L-NAME; and (5) quercetin (10 mg/kg p.o.) plus L-NAME.
Methods: The evolution of systolic blood pressure, morphological variables, proteinuria, plasma malondialdehyde and nitrite and nitrate concentrations, hepatic glutathione and malondialdehyde content, glutathione enzymes activity and vascular reactivity at the end of the experiment were analysed.
Results: Quercetin markedly inhibited the development of L-NAME-induced hypertension. This effect was accompanied by a partial or full prevention of most of the effects induced by L-NAME, such as: (1) increases in the left ventricular and kidney weight indices; (2) proteinuria; (3) renal histological lesions, including hyaline arteriopathy and thickening of the vascular wall with moderate decrease of the lumen; (4) increased endothelium-dependent contraction; (5) increased vascular thromboxane B2 (TXB2) synthesis; (6) reduced plasma concentrations of nitrites plus nitrates (NOx); (7) increased plasma and hepatic malondialdehyde (MDA) concentrations; and (8) reduced glutathione peroxidase activity. In most cases these effects were dose dependent, but none of them were observed in normotensive animals.
Conclusions: This study confirms and extends the previous evidence about the antihypertensive effects and end-organ protection of the flavonoid quercetin in animal models of hypertension.
Comment in
-
Antihypertensive effect and end-organ protection of flavonoids: some insights, more questions.J Hypertens. 2002 Sep;20(9):1721-4. doi: 10.1097/00004872-200209000-00013. J Hypertens. 2002. PMID: 12195110 Review. No abstract available.
Similar articles
-
Modulatory properties of cardiac and quercetin glycosides from Dacryodes edulis seeds during L-NAME-induced vascular perturbation.J Basic Clin Physiol Pharmacol. 2020 Jul 11;31(5):/j/jbcpp.2020.31.issue-5/jbcpp-2019-0116/jbcpp-2019-0116.xml. doi: 10.1515/jbcpp-2019-0116. J Basic Clin Physiol Pharmacol. 2020. PMID: 32653874 Review.
-
Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.Br J Nutr. 2011 Nov;106(9):1337-48. doi: 10.1017/S0007114511004314. Epub 2011 Sep 13. Br J Nutr. 2011. PMID: 21910946
-
Antihypertensive effects of the flavonoid quercetin.Pharmacol Rep. 2009 Jan-Feb;61(1):67-75. doi: 10.1016/s1734-1140(09)70008-8. Pharmacol Rep. 2009. PMID: 19307694 Review.
-
Effects of losartan on blood pressure, oxidative stress, and nitrate/nitrite levels in the nitric oxide deficient hypertensive rats.Recept Channels. 2004;10(5-6):147-57. doi: 10.3109/10606820490936141. Recept Channels. 2004. PMID: 15989079
-
Effects of chronic quercetin treatment in experimental renovascular hypertension.Mol Cell Biochem. 2005 Feb;270(1-2):147-55. doi: 10.1007/s11010-005-4503-0. Mol Cell Biochem. 2005. PMID: 15792364
Cited by
-
Iranian traditional medicinal plants for management of chronic heart failure: A review.Medicine (Baltimore). 2023 May 12;102(19):e33636. doi: 10.1097/MD.0000000000033636. Medicine (Baltimore). 2023. PMID: 37171363 Free PMC article. Review.
-
Catechins: Protective mechanism of antioxidant stress in atherosclerosis.Front Pharmacol. 2023 Mar 24;14:1144878. doi: 10.3389/fphar.2023.1144878. eCollection 2023. Front Pharmacol. 2023. PMID: 37033663 Free PMC article. Review.
-
Oxidative Stress, Antioxidants and Hypertension.Antioxidants (Basel). 2023 Jan 27;12(2):281. doi: 10.3390/antiox12020281. Antioxidants (Basel). 2023. PMID: 36829839 Free PMC article. Review.
-
Flavonoids in Treatment of Chronic Kidney Disease.Molecules. 2022 Apr 6;27(7):2365. doi: 10.3390/molecules27072365. Molecules. 2022. PMID: 35408760 Free PMC article. Review.
-
New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases.Mol Med. 2021 Sep 30;27(1):123. doi: 10.1186/s10020-021-00358-4. Mol Med. 2021. PMID: 34592918 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources